Metabolic Syndrome and psoriatic arthritis: considerations for the clinician

被引:28
作者
Caso, Francesco [1 ]
Chimenti, Maria Sole [2 ]
Navarini, Luca [3 ]
Ruscitti, Piero [4 ]
Peluso, Rosario [1 ]
Girolimetto, Nicolo [1 ,5 ]
Del Puente, Antonio [1 ]
Giacomelli, Roberto [4 ]
Scarpa, Raffaele [1 ]
Costa, Luisa [1 ]
机构
[1] Univ Federico II, Dept Clin Med & Surg, Rheumatol Unit, Via Sergio Pansini 5, I-80131 Naples, Italy
[2] Univ Roma Tor Vergata, Dept Syst Med, Rheumatol Allergol & Clin Immunol, Rome, Italy
[3] Univ Campus Biomed Roma, Unit Allergol Clin Immunol & Rheumatol, Rome, Italy
[4] Univ Aquila, Dept Biotechnol & Appl Clin Sci, Rheumatol Unit, Laquila, Italy
[5] Azienda USL IRCCS Reggio Emilia, Dept Rheumatol, Reggio Emilia, Italy
关键词
Psoriatic arthritis; Metabolic Syndrome; cardiovascular risk; obesity; adipokines; CARDIOVASCULAR RISK-FACTORS; QUALITY-OF-LIFE; CONTRAST-ENHANCED ULTRASOUND; DISEASE-ACTIVITY STATE; BODY-MASS INDEX; RHEUMATOID-ARTHRITIS; SUBCLINICAL ATHEROSCLEROSIS; TNF-ALPHA; PHARMACOLOGICAL-TREATMENT; ANKYLOSING-SPONDYLITIS;
D O I
10.1080/1744666X.2020.1740593
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction: Metabolic Syndrome (MetS) is strictly interconnected with systemic inflammation, and increased evidence has described a close link between this condition and Psoriatic Arthritis (PsA). Areas covered: This review summarizes main studies exploring clinical aspects and prevalence of MetS in PsA cohorts. Further, there is accumulating evidence showing shared inflammatory pathways between MetS, its components, and PsA. Expert opinion: The high prevalence of MetS in PsA highlights the need for screening, evaluation, and close monitoring of MetS and its components (namely, diabetes mellitus, obesity, hypertension, and dyslipidemia) in psoriatic patients. Further studies should focus on the pathogenetic link between MetS and PsA. More studies are required to identify appropriate algorithms for the assessment and management of MetS in PsA patients.
引用
收藏
页码:409 / 420
页数:12
相关论文
共 194 条
[41]   Crosstalk between skin inflammation and adipose tissue-derived products: pathogenic evidence linking psoriasis to increased adiposity [J].
Chiricozzi, Andrea ;
Raimondo, Annunziata ;
Lembo, Serena ;
Fausti, Francesca ;
Dini, Valentina ;
Costanzo, Antonio ;
Monfrecola, Giuseppe ;
Balato, Nicola ;
Ayala, Fabio ;
Romanelli, Marco ;
Balato, Anna .
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2016, 12 (12) :1299-1308
[42]   Small molecules and antibodies for the treatment of psoriasis: a patent review (2010-2015) [J].
Chiricozzi, Andrea ;
Saraceno, Rosita ;
Novelli, Lucia ;
Fida, Monika ;
Caso, Francesco ;
Scarpa, Raffaele ;
Costa, Luisa ;
Perricone, Roberto ;
Romanelli, Marco ;
Chimenti, Sergio ;
Chimenti, Maria Sole .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2016, 26 (07) :756-765
[43]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[44]   Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis [J].
Coates, Laura C. ;
Kavanaugh, Arthur ;
Mease, Philip J. ;
Soriano, Enrique R. ;
Acosta-Felquer, Maria Laura ;
Armstrong, April W. ;
Bautista-Molano, Wilson ;
Bochncke, Wolf -Henning ;
Campbc, Willemina ;
Cauli, Alberto ;
Espinoza, Luis R. ;
FitzGerald, Oliver ;
Gladman, Dafna D. ;
Gottlieb, Alice ;
Helliwel, Philip S. ;
Husni, M. Elaine ;
Love, Thorvardur J. ;
Lubrano, Ennio ;
McHugh, Neil ;
Nash, Peter ;
Ogdie, Alexis ;
Orbai, Ana -Maria ;
Parkinson, Andrew ;
O'Sullivan, Denis ;
Rosen, Cheryl F. ;
Schwartzman, Sergio ;
Siege, Evan L. ;
Toloza, Sergio ;
Tuong, William ;
Ritchlin, Christopher T. .
ARTHRITIS & RHEUMATOLOGY, 2016, 68 (05) :1060-1071
[45]   Psoriatic arthritis and obesity: the role of anti-IL-12/IL-23 treatment [J].
Costa, Luisa ;
Ramonda, Roberta ;
Ortolan, Augusta ;
Favero, Marta ;
Foti, Rosario ;
Visalli, Elisa ;
Rossato, Marco ;
Cacciapaglia, Fabio ;
Lapadula, Giovanni ;
Scarpa, Raffaele .
CLINICAL RHEUMATOLOGY, 2019, 38 (09) :2355-2362
[46]   Switching Between Biological Treatments in Psoriatic Arthritis: A Review of the Evidence [J].
Costa, Luisa ;
Perricone, Carlo ;
Chimenti, Maria Sole ;
Del Puente, Antonio ;
Caso, Paolo ;
Peluso, Rosario ;
Bottiglieri, Paolo ;
Scarpa, Raffaele ;
Caso, Francesco .
DRUGS IN R&D, 2017, 17 (04) :509-522
[47]   Small molecule therapy for managing moderate to severe psoriatic arthritis [J].
Costa, Luisa ;
Del Puente, Antonio ;
Peluso, Rosario ;
Tasso, Marco ;
Caso, Paolo ;
Chimenti, Maria Sole ;
Sabbatino, Vincenzo ;
Girolimetto, Nicolo ;
Benigno, Carolina ;
Bertolini, Nicoletta ;
Del Puente, Aurora ;
Perricone, Roberto ;
Scarpa, Raffaele ;
Caso, Francesco .
EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (15) :1557-1567
[48]   Incidence of Malignancies in a Cohort of Psoriatic Arthritis Patients Taking Traditional Disease Modifying Antirheumatic Drug and Tumor Necrosis Factor Inhibitor Therapy: An Observational Study [J].
Costa, Luisa ;
Caso, Francesco ;
Del Puente, Antonio ;
Di Minno, Matteo Nicola Dario ;
Peluso, Rosario ;
Scarpa, Raffaele .
JOURNAL OF RHEUMATOLOGY, 2016, 43 (12) :2149-2154
[49]   Metabolic syndrome and its relationship with the achievement of minimal disease activity state in psoriatic arthritis patients: an observational study [J].
Costa, Luisa ;
Caso, Francesco ;
Ramonda, Roberta ;
Del Puente, Antonio ;
Cantarini, Luca ;
Darda, Md Abud ;
Caso, Paolo ;
Lorenzin, Mariagrazia ;
Fiocco, Ugo ;
Punzi, Leonardo ;
Scarpa, Raffaele .
IMMUNOLOGIC RESEARCH, 2015, 61 (1-2) :147-153
[50]   Impact of 24-month treatment with etanercept, adalimumab, or methotrexate on metabolic syndrome components in a cohort of 210 psoriatic arthritis patients [J].
Costa, Luisa ;
Caso, Francesco ;
Atteno, Mariangela ;
Del Puente, Antonio ;
Darda, Md Abud ;
Caso, Paolo ;
Ortolan, Augusta ;
Fiocco, Ugo ;
Ramonda, Roberta ;
Punzi, Leonardo ;
Scarpa, Raffaele .
CLINICAL RHEUMATOLOGY, 2014, 33 (06) :833-839